Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

ENTPD1

From Wikipedia, the free encyclopedia
Mammalian protein found in humans

ENTPD1
Identifiers
AliasesENTPD1, ATPDase, CD39, NTPDase-1, SPG64, ectonucleoside triphosphate diphosphohydrolase 1
External IDsOMIM:601752;MGI:102805;HomoloGene:20423;GeneCards:ENTPD1;OMA:ENTPD1 - orthologs
Gene location (Human)
Chromosome 10 (human)
Chr.Chromosome 10 (human)[1]
Chromosome 10 (human)
Genomic location for ENTPD1
Genomic location for ENTPD1
Band10q24.1Start95,711,779bp[1]
End95,877,266bp[1]
Gene location (Mouse)
Chromosome 19 (mouse)
Chr.Chromosome 19 (mouse)[2]
Chromosome 19 (mouse)
Genomic location for ENTPD1
Genomic location for ENTPD1
Band19 C3|19 34.25 cMStart40,600,810bp[2]
End40,730,046bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • saphenous vein

  • monocyte

  • popliteal artery

  • tibial arteries

  • tendon of biceps brachii

  • gallbladder

  • right coronary artery

  • urethra

  • blood

  • appendix
Top expressed in
  • ascending aorta

  • aortic valve

  • granulocyte

  • spermatocyte

  • spermatid

  • atrioventricular valve

  • lens

  • stroma of bone marrow

  • conjunctival fornix

  • carotid body
More reference expression data
BioGPS




More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

953

12495

Ensembl

ENSG00000138185

ENSMUSG00000048120

UniProt

P49961

P55772

RefSeq (mRNA)
NM_001098175
NM_001164178
NM_001164179
NM_001164181
NM_001164182

NM_001164183
NM_001312654
NM_001776
NM_001320916

NM_009848
NM_001304721

RefSeq (protein)
NP_001091645
NP_001157650
NP_001157651
NP_001157653
NP_001157654

NP_001157655
NP_001299583
NP_001307845
NP_001767

NP_001291650
NP_033978

Location (UCSC)Chr 10: 95.71 – 95.88 MbChr 19: 40.6 – 40.73 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Ectonucleoside triphosphate diphosphohydrolase-1 (gene:ENTPD1; protein:NTPDase1) also known asCD39 (Cluster ofDifferentiation39), is a typical cell surface enzyme with a catalytic site on the extracellular face.[5][6][7]

Function

[edit]

NTPDase1 is anectonucleotidase that catalyse the hydrolysis of γ- and β-phosphate residues of triphospho- and diphosphonucleosides to the monophosphonucleoside derivative.[8][9] NTPDase1 hydrolyzesP2 receptor ligands, namelyATP,ADP, UTP and UDP with similar efficacy.[10] NTPDase1 can therefore affect P2 receptor activation and functions.[11]

Clinical significance

[edit]

ATP causes a pro-inflammatory environment, whereas degradation of ATP intoadenosine by the CD39/CD73 pathway leads to an anti-inflammatory environment.[12] CD39 converts ATP (or ADP) toadenosine monophosphate (AMP), which is converted into adenosine by CD73.[12][13] A substantial portion of the immune suppressive and anti-inflammatory activity ofregulatory T cells (Tregs) is due to the adenosine produced by the CD39/CD73 pathway, insofar as Tregs express CD39 and CD73.[12][13]

Adenosine produced by the CD39/CD73 pathway can protect againstischemia-reperfusion injury.[12] On the other hand, high expression and activity of CD39 and CD73 oncancer cells can prevent the immune system from inhibiting the progression of cancer.[12]

Biallelic pathogenic variant in ENTPD1 causes autosomal recessive spastic paraplegia 64 (SPG64).[14][15] SPG64 is a complex hereditary spastic paraplegia characterized by childhood onset progressive spastic paraparesis, delayed developmental milestones, intellectual disability, dysarthria, and white matter abnormalities.

See also

[edit]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000138185Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000048120Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^"Entrez Gene: ENTPD1 Ectonucleoside triphosphate diphosphohydrolase 1".
  6. ^Sévigny J, Levesque FP, Grondin G, Beaudoin AR (Feb 1997). "Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques".Biochimica et Biophysica Acta (BBA) - General Subjects.1334 (1):73–88.doi:10.1016/s0304-4165(96)00079-7.PMID 9042368.
  7. ^Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (Dec 1996)."Identification and characterization of CD39/vascular ATP diphosphohydrolase".The Journal of Biological Chemistry.271 (51):33116–22.doi:10.1074/jbc.271.51.33116.PMID 8955160.
  8. ^Robson SC, Sévigny J, Zimmermann H (Jun 2006)."The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance".Purinergic Signalling.2 (2):409–30.doi:10.1007/s11302-006-9003-5.PMC 2254478.PMID 18404480.
  9. ^Yegutkin GG (May 2008)."Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade".Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.1783 (5):673–94.doi:10.1016/j.bbamcr.2008.01.024.PMID 18302942.
  10. ^Kukulski F, Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, Robson SC, Kirley TL, Sévigny J (Jun 2005)."Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8".Purinergic Signalling.1 (2) 193:193–204.doi:10.1007/s11302-005-6217-x.PMC 2096530.PMID 18404504.
  11. ^Kukulski F, Lévesque SA, Sévigny J (2011-01-01). "Impact of ectoenzymes on p2 and p1 receptor signaling".Pharmacology of Purine and Pyrimidine Receptors. Advances in Pharmacology. Vol. 61. pp. 263–99.doi:10.1016/B978-0-12-385526-8.00009-6.ISBN 978-0-12-385526-8.PMID 21586362.
  12. ^abcdeAntonioli L, Pacher P, Vizi ES, Haskó G (2013)."CD39 and CD73 in immunity and inflammation".Trends in Molecular Medicine.19 (6):355–367.doi:10.1016/j.molmed.2013.03.005.PMC 3674206.PMID 23601906.
  13. ^abSepúlveda C, Palomo I, Fuentes E (2016). "Role of adenosine A2b receptor overexpression in tumor progression".Life Sciences.166:92–99.doi:10.1016/j.lfs.2016.10.008.PMID 27729268.
  14. ^Novarino G, Fenstermaker AG, Zaki MS, et al. (Jan 2014)."Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders".Science.343 (6170):506–511.Bibcode:2014Sci...343..506N.doi:10.1126/science.1247363.PMC 4157572.PMID 24482476.
  15. ^Calame DG, Herman I, Maroofian R, et al. (Aug 2022)."Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia".Ann Neurol.92 (2):304–321.doi:10.1002/ana.26381.hdl:1887/3564840.PMC 10054521.PMID 35471564.

Further reading

[edit]

External links

[edit]
1–50
51–100
101–150
151–200
201–250
251–300
301–350
Retrieved from "https://en.wikipedia.org/w/index.php?title=ENTPD1&oldid=1301009541"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp